Patents

List of patents

  • “METHOD FOR PREDICTING THE SURVIVAL TIME OF A PATIENT SUFFERING FROM HEPATOCELLULAR CARCINOMA”. EP17305436.2 ; 12/04/2017.
  • DECISION DE DEPOT D’UN DOSSIER DE PROTECTION DE PROGRAMMES. N.REF : PDA16425 MUSSO/NC. Titre : Database on HCC. Date : 19/10/2016. Inserm Transfert.
  • Corlu A, Dianat N, Dubart Kupperschmitt A, Weber Benarous A (2016) A method for inducing human cholangiocyte differentiation. – EP14305387. Licence d’exploitation; Société Biopredic, 15/12/2016 - (INSERM UMR991– Rennes)
  • Herault O. (2015) « Hemopathy prognosis method » - Brevet WO2016083742 du 26/11/2015 - (MNT team: CNRS UMR 7292 LNOx - Tours)
  • Methods for diagnosing and monitoring the response to treatment of hepatocellular carcinoma – C Coulouarn, M Ozturk and B Clément (INSERM U991 – Rennes ‐ European Patent Office, PCT EP2014/058293 – 2014 – B Clément A Corlu team
  • A method for inducing human cholangiocyte differentiation. N Dianat, A, Weber, A Corlu, A. Dubart-Kupperschmitt; Fr EP14305387, 19 March 2014– B Clément A Corlu team
  • Vignon C, Debeissat C, Georget MT, Bouscary D, Gyan E, Rosset P, Herault O. (2013) Flow cytometric quantification of all phases of the cell cycle and apoptosis in a two-color fluorescence plot. PLOS One, 8:e68425 (IF2012=3,730) - (MNT team: CNRS UMR 7292 LNOx - Tours)
  • Bire S, Ley D, Casteret S, Mermod N, Bigot Y, Rouleux-Bonnin F. (2013) Optimization of the piggyBac transposon using mRNA and insulators: Toward a more reliable gene delivery system. PLoS One, 8:e82559 (IF2012=3,730) - (MNT team: CNRS UMR 7292 LNOx - Tours)
  • Bire S, Gosset D, Jégot G, Midoux P, Pichon C, Rouleux-Bonnin F. (2013) Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition. BMC Biotechnol, 13:75 (IF2012=2,165) - (MNT team: CNRS UMR 7292 LNOx - Tours)
  • Respaud R, Quenuma L, Plichon C, Tournamille JF, Gyan E, Antier D, Viaud-Massuard MC. (2013) A stability-indicating, ion-pairing, reversed-phase liquid chromatography method for studies of daunorubicin degradation in i.v. infusion fluids. J Pharm Biomed Anal, 83:164–170 (IF2011=2,967) - (MNT team: CNRS UMR 7292 LNOx - Tours)
  • Methods for predicting the survival time of patients suffering from diffuse large B-cell lymphomas - Delphine Rossille and Thierry Fest (Inserm U917 – Rennes) - EP13305145 – 2013 – K Tarte team. (MNT Team: INSERM UMR 917 – Rennes)
  • WO/2013/093039* A1 (PCT/EP2012/076729) Nantes University/ Nantes Hospital, Heymann D, Stresing V, Télétchéa S. Peptides targeting RANK and their applications. – (MNT team: INSERM UMR 957 - Nantes)
  • EP/14306175.2 INSERM/Nantes University. Gamblin AL, Trichet V, Layrolle P. Bone regenerating biomaterials with selected cells from peripheral blood – (MNT team: INSERM UMR 957 - Nantes)
  • Patent WO2012022634-A1: In vitro classifying a multiple myeloma (MM) comprises a) determining in a MM cell line the expression level of genes, and b) classifying the MM cell line based on the expression levels determined at step a). (INSERM, Klein B; Moreaux J; Pellat-Deceunynck C). - (MNT Team: INSERM UMR 892/CNRS 6299 team 10 – Nantes)
  • Herault O, Vignon C. (2012) « Method for diagnosing hematological disorders » – Brevet WO2012085188 A1 du 28 juin 2012 (caractérisation à visée diagnostique de l’expression des gènes antioxydants, signature antioxydante dans les hémopathies ou « antioxydogramme ») - (MNT team: CNRS UMR 7292 LNOx - Tours)
  • Palazzoli F, Bire S, Bigot Y, Bonnin-Rouleux F. (2011) Landscape of chromatin control element patents: positioning effects in pharmaceutical bioproduction. Nat Biotechnol, 29:593-597- (MNT team: CNRS UMR 7292 LNOx - Tours)
  • 2013 international n°11704276.2 « Human and murine stem cell lines: models of endothelial cell precursors » - (MNT Team: CNRS UPR4301 CBM)
  • 2011 International WO 2011/083285 A1 « Organ-specific feline endothelial cells and their uses thereof » - (MNT Team: CNRS UPR4301 CBM)
  • 2009 USA n° 61/223,583 "Method of reducing MDR by ITPP"  – (MNT Team: CNRS UPR4301 CBM)
  • Use of FZC18‐containing collagen 18 polypeptides for the treatment, diagnosis and outcome prediction of diseases – O. Musso, E Lavergne, D Quelard, I Hendaoui, B Clement (INSERM U991 – Rennes) ‐ European Patent Office EPO‐7301681.8, PCT/EP2008/067779 – 2007– B Clément A Corlu team
  • Determining levels of type XVIII collagen for detection or monitoring of liver diseases – T Pihlajaniemi, M Rehn and B Clément (INSERM U991 – Rennes) ‐ US Patent n°09/094,967– B Clément A Corlu team